Evidence map›Paper›PMID 25816778›Full record

ArticleThe American journal of cardiology2015

Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).

Adam Mitchell, Jeffrey R Misialek, Aaron R Folsom, Daniel Duprez, Alvaro Alonso, Michael Jerosch-Herold, Otto A Sanchez, Karol E Watson, Tamer Sallam, Suma H Konety

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The American journal of cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Adam MitchellDivision of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Jeffrey R MisialekDivision of Epidemiology and Community Health School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Aaron R FolsomDivision of Epidemiology and Community Health School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Daniel DuprezDivision of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Alvaro AlonsoDivision of Epidemiology and Community Health School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Michael Jerosch-HeroldDepartment of Radiology, Brigham and Woman's Hospital, Boston, Massachusetts.
Otto A SanchezDivision of Epidemiology and Community Health School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Karol E WatsonDivision of Cardiology, University of California Los Angeles, Los Angeles, California.
Tamer SallamDivision of Cardiology, University of California Los Angeles, Los Angeles, California.
Suma H KonetyDivision of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. Electronic address: shkonety@umn.edu.
University of Minnesota · USUniversity of California, Los Angeles · USWoman's Hospital · US

Funding

SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTERN01HC95163 · NHLBI · UNIVERSITY OF MINNESOTA · PI FOLSOM, AARON R · 2007 to 2014
$6.1M
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTERN01HC095163 · HC · UNIVERSITY OF MINNESOTA TWIN CITIES · PI FOLSOM, AARON R · 1999 to 2001
$443k
NHLBI NIH HHS N01 HC095163NHLBI NIH HHS N01 HC95163
6 · The paper itself

Abstract

This study sought to investigate the relation between myocardial perfusion and N-terminal pro-brain natriuretic peptide (NT-proBNP) in asymptomatic adults without overt coronary artery disease. NT-proBNP is a cardiac neurohormone secreted from the ventricles in response to ventricular volume expansion and pressure overload and may also be elevated in the setting of reduced myocardial perfusion. We hypothesized that reduced myocardial perfusion reserve (MPR) would be associated with elevated NT-proBNP in participants free of overt cardiovascular disease. MPR was measured by cardiac magnetic resonance, before and after adenosine infusion, in 184 MESA participants (mean age 60 ± 10.4, 58% white, 42% Hispanic, 44% women) without overt cardiovascular disease. MPR was modeled as hyperemic myocardial blood flow (MBF) adjusted for MBF at rest. A linear regression analysis, adjusted for demographics, established cardiovascular risk factors, left ventricular mass, coronary calcium score, body mass index, and medications, was used to determine the association between MPR and NT-proBNP. Participants with low hyperemic MBF were more likely to be older, male, diabetic, and have higher blood pressure and higher coronary artery calcium score. Mean hyperemic MBF was 3.04 ± 0.829 ml/min/g. MPR was inversely associated with NT-proBNP levels. In a fully adjusted model, every 1-SD decrement in MPR was associated with a 21% increment in NT-proBNP (p = 0.04). In conclusion, MPR is inversely associated with NT-proBNP level in this cross-sectional study of asymptomatic adults free of overt coronary artery disease, suggesting that higher NT-proBNP levels may reflect subclinical myocardial microvascular dysfunction.

Indexed as

EthnicityAgedAged, 80 and overAsymptomatic DiseasesAtherosclerosisCoronary Artery DiseaseCoronary CirculationCross-Sectional StudiesElectrocardiographyFemaleFollow-Up StudiesHumansIncidenceMagnetic Resonance Imaging, CineMaleMiddle AgedNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Protein Precursors

Identifiers

PMID25816778
PMCPMC4414796
OpenAlexW2029511555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.